AAAAAA

   
Results: 1-10 |
Results: 10
Combination gemcitabine and docetaxel therapy in advanced adenocarcinoma of the pancreas
Authors: Sherman, WH Fine, RL
Citation: Wh. Sherman et Rl. Fine, Combination gemcitabine and docetaxel therapy in advanced adenocarcinoma of the pancreas, ONCOL-BASEL, 60(4), 2001, pp. 316-321
Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells
Authors: Kanovsky, M Raffo, A Drew, L Rosal, R Do, T Friedman, FK Rubinstein, P Visser, J Robinson, R Brandt-Rauf, PW Michl, J Fine, RL Pincus, MR
Citation: M. Kanovsky et al., Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells, P NAS US, 98(22), 2001, pp. 12438-12443
Formation of nuclear Bax/p53 complexes is associated with chemotherapy induced apoptosis
Authors: Raffo, AJ Kim, AL Fine, RL
Citation: Aj. Raffo et al., Formation of nuclear Bax/p53 complexes is associated with chemotherapy induced apoptosis, ONCOGENE, 19(54), 2000, pp. 6216-6228
Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model
Authors: Kaiser, MG Parsa, AT Fine, RL Hall, JS Chakrabarti, I Bruce, JN
Citation: Mg. Kaiser et al., Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model, NEUROSURGER, 47(6), 2000, pp. 1391-1398
Intracerebral clysis in a rat glioma model
Authors: Bruce, JN Falavigna, A Johnson, JP Hall, JS Birch, BD Yoon, JT Wu, EX Fine, RL Parsa, AT
Citation: Jn. Bruce et al., Intracerebral clysis in a rat glioma model, NEUROSURGER, 46(3), 2000, pp. 683-691
The rise and fall of the futility movement.
Authors: Fine, RL Mayo, TW
Citation: Rl. Fine et Tw. Mayo, The rise and fall of the futility movement., N ENG J MED, 343(21), 2000, pp. 1575-1576
Phase I and pharmacokinetic analysis of high-dose tamoxifen and chemotherapy in normal and tumor-bearing dogs
Authors: Waddle, JR Fine, RL Case, BC Trogdon, ML Tyczkowska, K Frazier, D Page, RL
Citation: Jr. Waddle et al., Phase I and pharmacokinetic analysis of high-dose tamoxifen and chemotherapy in normal and tumor-bearing dogs, CANC CHEMOT, 44(1), 1999, pp. 74-80
Conformational and molecular basis for induction of apoptosis by a p53 C-terminal peptide in human cancer cells
Authors: Kim, AL Raffo, AJ Brandt-Rauf, PW Pincus, MR Monaco, R Abarzua, P Fine, RL
Citation: Al. Kim et al., Conformational and molecular basis for induction of apoptosis by a p53 C-terminal peptide in human cancer cells, J BIOL CHEM, 274(49), 1999, pp. 34924-34931
Differential phosphorylation of sites in the linker region of P-glycoprotein by protein kinase C isozymes alpha, beta I, beta II, gamma, delta, epsilon, eta, and zeta
Authors: Sachs, CW Chambers, TC Fine, RL
Citation: Cw. Sachs et al., Differential phosphorylation of sites in the linker region of P-glycoprotein by protein kinase C isozymes alpha, beta I, beta II, gamma, delta, epsilon, eta, and zeta, BIOCH PHARM, 58(10), 1999, pp. 1587-1592
Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinoma
Authors: Cheng, AL Yeh, KH Fine, RL Chuang, SE Yang, CH Wang, LH Chen, DS
Citation: Al. Cheng et al., Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinoma, HEP-GASTRO, 45(24), 1998, pp. 1955-1960
Risultati: 1-10 |